News on Megestrol_Acetate from BioPortfolio.com http://www.BioPortfolio.com Consolidated Megestrol_Acetate news from BioPortfolio.com Wed, 10 Feb 2010 09:02:48 GMT en Thalidomide-Based Therapy Prevents Weight Loss in Patients With Advanced GI Cancer: Presented at ASCO-GIhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959212&HITNO=0&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959212&THISHREF=http://c.moreover.com/click/here.pl%3fz2495678054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959212&HITNO=0&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959212&THISHREF=http://c.moreover.com/click/here.pl%3fz2495678054%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Ipsen runs clinical trials on cancer drug designed by Bath researchershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952160&HITNO=1&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952160&THISHREF=http://c.moreover.com/click/here.pl%3fz2490628046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3952160&HITNO=1&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3952160&THISHREF=http://c.moreover.com/click/here.pl%3fz2490628046%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUniversity of Bath: Immunotec Announces commencement of IMN 1207 US Lung Cancer Study funded by Moffitt Cancer Center CCOP Researchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3746191&HITNO=2&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3746191&THISHREF=http://c.moreover.com/click/here.pl%3fz2385145604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3746191&HITNO=2&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3746191&THISHREF=http://c.moreover.com/click/here.pl%3fz2385145604%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ipsen Initiates an Advanced Endometrial Cancer Program with BN83495, its First-in-Class Steroid Sulfatase (STShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3694059&HITNO=3&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3694059&THISHREF=http://c.moreover.com/click/here.pl%3fz2359309761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3694059&HITNO=3&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3694059&THISHREF=http://c.moreover.com/click/here.pl%3fz2359309761%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Ipsen Initiates an Advanced Endometrial Cancer Program with BN83495, its First-in-Class Steroid Sulfatase (STShttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3689312&HITNO=4&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3689312&THISHREF=http://c.moreover.com/click/here.pl%3fz2357510470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3689312&HITNO=4&MSIZE=5&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Megestrol_Acetate&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3689312&THISHREF=http://c.moreover.com/click/here.pl%3fz2357510470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: